Esofagitis eosinofílica y esofagitis infecciosas y tóxicas

  1. Macías García, F. 1
  2. Domínguez Muñoz, J.E. 1
  1. 1 Servicio de Aparato Digestivo, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, La Coruña, España
Revista:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Ano de publicación: 2020

Título do exemplar: Enfermedades del aparato digestivo (VII)Enfermedades del esófago

Serie: 13

Número: 7

Páxinas: 384-391

Tipo: Artigo

DOI: 10.1016/J.MED.2020.05.003 DIALNET GOOGLE SCHOLAR

Outras publicacións en: Medicine: Programa de Formación Médica Continuada Acreditado

Resumo

Oesophagitis is a group of entities that have in common the injury and inflammation of the oesophageal mucosa. In addition to gastro-oesophageal reflux, there are numerous aetiologies for these entities, including drugs, infectious agents and their involvement in the context of immunoallergic diseases. Dysphagia, odynophagia, chest pain and food impaction are usually the most common symptomatic manifestations. In this update, we cover the most common types of oesophagitis (except gastro-oesophageal reflux disease), from the clinical diagnosis to the subsequent therapeutic management.

Referencias bibliográficas

  • Lucendo AJ, Molina-Infante J, Arias A, von Arnim U, Bredenoord AJ, Bussmann C, et al. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. United European Gas-troenterol J. 2017;5(3):335-58.
  • Dellon ES, Liacouras CA, Molina-Infante J, Furuta GT, Spergel JM, Zevit N, et al. Updated international consensus diagnostic cri-teria for eosinophilic esophagitis: Proceedings of the AGREE conference. Gastroenterology. 2018;155:1022-33.
  • Attwood SE, Smyrk TC, Demeester TRJJ. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci. 1993;38: 109-16.
  • Greenhawt M, Aceves SS, Spergel JM, Rothenberg ME. The management of eosinophilic esophagitis. J Allergy Clin Immunol Pract. 2013;1(4): 332-40.
  • Gonsalves N. Distinct features in the clinical presentations of eosinophi-lic esophagitis in children and adults: is this the same disease? Dig Dis. 2014;32(1-2):89-92.
  • Straumann A. The natural history and complications of eosinophilic esophagitis. Thorac Surg Clin. 2011;21:575-87.
  • Dellon ES, Hirano I. Epidemiology and natural history of eosinophilic esophagitis. Gastroenterology. 2018;154:319-22.
  • Dellon ES, Gibbs WB, Fritchie KJ, Rubinas TC, Wilson LA, Woosley JT, et al. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol He-patol. 2009;7:1305-13.
  • Schoepfer AM, Safroneeva E, Bussmann C, Kuchen T, Portmann S, Simon HU, et al. Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterolo-gy. 2013;145:1230-6.
  • Dellon ES, Kim HP, Sperry SL, Rybnicek DA, Woosley JT, Shaheen NJ. A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease. Gastrointest Endosc. 2014;79:577-85.
  • Dellon ES. Diagnostics of eosinophilic esophagitis: clinical, endoscopic, and histologic pitfalls. Dig Dis. 2014;32(1-2):48-53.
  • Cotton CC, Eluri S, Wolf WA, Dellon ES. Six-food elimination diet and topical steroids are effective for eosinophilic esophagitis: a meta-regression. Dig Dis Sci. 2017;62:2408-20.
  • Lucendo AJ, Arias A, Molina-Infante J. Efficacy of proton pump inhibitor drugs for inducing clinical and histologic remission in patients with symptomatic esophageal eosinophilia: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;14:13-22.
  • Dellon ES, Liacouras CA. Advances in clinical management of eosinophilic esophagitis. Gastroenterology. 2014;147:1238-54.
  • Imam T, Gupta SK. Topical glucocorticoid vs. diet therapy in eosinophilic esophagitis: the need for better treatment options. Expert Rev Clin Im-munol. 2016;12:797-9.
  • Dougherty M, Runge TM, Eluri S, Dellon ES. Esophageal dilation with either bougie or balloon technique as a treatment for eosinophilic esophagitis: a systematic review and meta-analysis. Gastrointest Endosc. 2017;86:581-91.
  • Arias A, González-Cervera J, Tenias JM, Lucendo AJ. Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis. Gastroenterology. 2014;146:1639-48.
  • Vázquez-Elizondo G, Ngamruengphong S, Khrisna M, Devault KR, Talley NJ, Achem SR. The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor. Aliment Pharmacol Ther. 2013;38:1312-9.
  • Moawad FJ, Veerappan GR, Dias JA, Baker TP, Maydonovitch CL, Wong RK. Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia. Am J Gastroenterol. 2013;108:366-72.
  • Molina-Infante J, Katzka DA, Gisbert JP. Review article: proton pump inhibitor therapy for suspected eosinophilic oesophagitis. Aliment Phar-macol Ther. 2013;37:1157-64.
  • Lucendo AJ, Arias A, Molina-Infante J. Efficacy of proton pump inhibitor drugs for inducing clinical and histologic remission in patients with symptomatic esophageal eosinophilia: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;14:13-22.
  • Tan N Di, Xiao YL, Chen MH. Steroids therapy for eosinophilic esophagitis: Systematic review and meta-analysis. J Dig Dis. 2015;16:431-42.
  • Sawas T, Dhalla S, Sayyar M, Pasricha PJ, Hernaez R. Systematic review with meta-analysis: pharmacological interventions for eosinophilic oesophagitis. Aliment Pharmacol Ther. 2015;41:797-806.
  • Murali AR, Gupta A, Attar BM, Ravi V, Koduru P. Topical steroids in eosinophilic esophagitis: systematic review and meta-analysis of placebo controlled randomized clinical trials. J Gastroenterol Hepatol. 2015;31: 1111-9.
  • Chuang M-YA, Chinnaratha MA, Hancock DG, Woodman R, Wong GR, Cock C, et al. Topical steroid therapy for the treatment of eosinophilic esophagitis (EoE): a systematic review and meta-analysis. Clin Transl Gastroenterol. 2015;6:e82.
  • Miehlke S, Hruz P, Vieth M, Bussmann C, von Arnim U, Bajbouj M, et al. A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis. Gut. 2016;65:390-9.
  • Straumann A, Conus S, Degen L, Frei C, Bussmann C, Beglinger C, et al. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2011; 9:400-9.
  • Arias A, González-Cervera J, Tenias JM, Lucendo AJ. Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis. Gastroenterolo-gy. 2014;146:1639-48.
  • Molina-Infante J, Arias A, Barrio J, Rodríguez-Sánchez J, Sánchez-Caza-lilla M, Lucendo AJ. Four-food group elimination diet for adult eosino-philic esophagitis: A prospective multicenter study. J Allergy Clin Immu-nol. 2014;134:1093-9.
  • Molina-Infante J, Modolell I, Alcedo J, García-Romero R, Casabona-Frances S, Prieto-Garcia A, et al. Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: the 2-4-6 study. United Eur Gastroenterol J. 2016;Suppl5:A126.
  • Lucendo AJ. Meta-analysis-based guidance for dietary management in eosinophilic esophagitis. Curr Gastroenterol Rep. 2015;17:464.
  • Arias A, González-Cervera J, Tenias JM, Lucendo AJ. Efficacy of dietary interventions for inducing histologic remission in patients with eosino-philic esophagitis: a systematic review and meta-analysis. Gastroenterology. 2014;146:1639-48.
  • Netzer P, Gschossmann JM, Straumann A, Sendensky A, Weimann R, Schoepfer AM. Corticosteroid-dependent eosinophilic oesophagitis: azathioprine and 6-mercaptopurine can induce and maintain long-term remission. Eur J Gastroenterol Hepatol. 2007;19:865-9.
  • O’Shea KM, Aceves SS, Dellon ES, Gupta SK, Spergel JM, Furu-ta GT, et al. Pathophysiology of eosinophilic esophagitis. Gastroenterology. 2018;154:333-45.
  • Wechsler JB, Hirano I. Biological therapies for eosinophilic gastrointestinal diseases. J Allergy Clin Immunol. 2018;142:24-31.
  • Moawad FJ, Cheatham JG, DeZee KJ. Meta-analysis: the safety and efficacy of dilation in eosinophilic oesophagitis. Aliment Pharmacol Ther. 2013;38:713-20.
  • O’Rourke A. Infective oesophagitis: epidemiology, cause, diagnosis and treatment options. Curr Opin Otolaryngol Head Neck Surg. 2015;23(6): 459-63.
  • Bustamante Balén M, Pertejo Pastor V. Esofagitis infecciosas. En: AEG Tratamiento de las enfermedades gastroenterológicas. 3ª ed. Barcelona: Elsevier Doyma; 2011. p. 49-58.
  • Zografos GN, Georgiadou D, Thomas D, Kaltsas G, Digalakis M. Drug-induced esophagitis. Dis Esophagus. 2009;22(8):633-7.
Fonte de datos: Dialnet